These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4937934)

  • 1. Modification of xenograft response by selective plasmapheresis.
    Merkel FK; Bier M; Beavers CD; Merriman WG; Wilson C; Starzl TE
    Transplant Proc; 1971 Mar; 3(1):534-7. PubMed ID: 4937934
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective plasmapheresis in dogs for delay of heterograft response.
    Bier M; Beavers CD; Merriman WG; Merkel FK; Eiseman B; Starzl TZ
    Trans Am Soc Artif Intern Organs; 1970; 16():325-33. PubMed ID: 4916739
    [No Abstract]   [Full Text] [Related]  

  • 3. Delay of the heterograft reaction by selective plasmapharesis.
    Merkel FK; Bier M; Beavers CD; Merriman WG; Starzl TE
    Surg Forum; 1970; 21():261-3. PubMed ID: 4105883
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between structural and functional changes in rejecting renal xenograft.
    Linn BS; Jensen JA; Pardo V; Davies D; Franklin L
    Transplant Proc; 1971 Mar; 3(1):527-30. PubMed ID: 4937932
    [No Abstract]   [Full Text] [Related]  

  • 5. Modification of hyperactue xenogeneic kidney rejection.
    Messmer K; Hammer C; Land W; Fiedler L; Klövekorn WP; Holper K; Lob G; Merzel D; Brendel W
    Transplant Proc; 1971 Mar; 3(1):542-4. PubMed ID: 4937936
    [No Abstract]   [Full Text] [Related]  

  • 6. Xenograft rejection by dog and man: isolated kidney perfusion with blood and plasma.
    Mozes MF; Gewurz H; Gunnarson A; Moberg AW; Westberg NG; Jetzer T; Najarian JS
    Transplant Proc; 1971 Mar; 3(1):531-3. PubMed ID: 4937933
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism and modification of rejection of heterografts between divergent species.
    Giles GR; Boehmig HJ; Lilly J; Amemiya H; Takagi H; Coburg AJ; Hathaway WE; Wilson CB; Dixon FJ; Starzl TE
    Transplant Proc; 1970 Dec; 2(4):522-38. PubMed ID: 4939700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of xenograft hyperacute rejection via xenoantibody depletion.
    Henry ML; Han LK; Orosz CG; Sedmak D; Ferguson RM
    Transplant Proc; 1990 Jun; 22(3):1081-2. PubMed ID: 2349665
    [No Abstract]   [Full Text] [Related]  

  • 9. Modification of hyperacute renal xenograft rejection after extracorporeal immunoadsorption of heterospecific antibody.
    Terman DS; Garcia-Rinaldi R; McCalmon R; Crumb CC; Mattioli C; Cook G; Poser R
    Int J Artif Organs; 1979 Jan; 2(1):35-41. PubMed ID: 387618
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of heparin, arvin, liver perfusion, and heterologous antiplatelet serum on rejection of pig kidney by dog.
    Slapak M; Greenbaum M; Bardawil W; Saravis C; Joison J; McDermott WV
    Transplant Proc; 1971 Mar; 3(1):558-61. PubMed ID: 4937939
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of modification of coagulation factors on xenograft rejection.
    Kashii A; Derry CD; Lafortune L; Sise H; P'eng FK; Sayhoun A; Misra MK; Slapak M
    Surg Forum; 1971; 22():242-4. PubMed ID: 4941307
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro studies on the mechanism of hyperacute xenograft rejection.
    Land W; Schilling A; Aldenhoff J; Lamerz R; Pielsticker K; Mendler N; Brendel W
    Transplant Proc; 1971 Mar; 3(1):888-90. PubMed ID: 4937986
    [No Abstract]   [Full Text] [Related]  

  • 13. Specificity of the heteroantibody in xenograft rejection.
    Mozes MF; Shons AR; Harris NS; Merino GE; Moberg AW; Campos RA; Najarian JS
    Surg Forum; 1971; 22():244-6. PubMed ID: 4941308
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement-mediated vasoconstriction and graft rejection.
    Jensen JA; Davies D; Linn BS; Snyderman R; Franklin L
    Circ Res; 1972 Mar; 30(3):332-40. PubMed ID: 4551266
    [No Abstract]   [Full Text] [Related]  

  • 15. [Modification of the hyperacute xenogeneic rejection].
    Land W; Brendel W; Hammer C; Holper K; Klövekorn WP; Lob G; Merzel D; Messmer K; Seifert J; Sunder-Plassmann L
    Res Exp Med (Berl); 1972; 157(3):259-62. PubMed ID: 4558283
    [No Abstract]   [Full Text] [Related]  

  • 16. Xenograft rejection mechanisms in man.
    Shons AR; Najarian JS
    Trans Am Soc Artif Intern Organs; 1974; 20 B():562-8. PubMed ID: 4615414
    [No Abstract]   [Full Text] [Related]  

  • 17. Delay of xenograft rejection through oxidation of blood during hemodialysis.
    Bier M; Zukoski F; Boyer JT; Beavers CD; Merriman WG
    Trans Am Soc Artif Intern Organs; 1971; 17():64-74. PubMed ID: 4945714
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of immunological injury during antibody-mediated hyperacute rejection of renal heterografts.
    Rosenberg JC; Hawkins E; Rector F
    Transplantation; 1971 Feb; 11(2):151-7. PubMed ID: 4931239
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolongation of renal xenografts by the simultaneous sequestration of preformed antibody, inhibition of complement, coagulation and antibody synthesis.
    Moberg AW; Shons AR; Gewurz H; Mozes M; Najarian JS
    Transplant Proc; 1971 Mar; 3(1):538-41. PubMed ID: 4937935
    [No Abstract]   [Full Text] [Related]  

  • 20. Modification of hyperacute canine renal homograft and pig-to-dog heterograft rejection by the intra-arterial infusion of citrate.
    Kux M; Boehmig HJ; Amemiya H; Torisu M; Yokoyama T; Launois B; Popovtzer M; Wilson CB; Dixon FJ; Starzl TE
    Surgery; 1971 Jul; 70(1):103-12. PubMed ID: 4933439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.